Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

NCT00856661 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

270

Enrollment

INDUSTRY

Sponsor class

Stopped The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol

Conditions

Stroke

Interventions

DRUG: Desmoteplase
DRUG: Placebo

Sponsor

H. Lundbeck A/S